1Life Healthcare, Inc.
ONEM · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.38 | -0.09 | -0.78 | 4.94 |
| FCF Yield | -8.67% | -5.64% | -1.30% | -3.19% |
| EV / EBITDA | -11.48 | -15.13 | -98.61 | -98.17 |
| Quality | ||||
| ROIC | -17.06% | -9.81% | -7.45% | -14.92% |
| Gross Margin | 17.64% | 29.98% | 38.20% | 39.33% |
| Cash Conversion Ratio | 0.53 | 0.35 | 0.04 | 0.60 |
| Growth | ||||
| Revenue 3-Year CAGR | 40.10% | 31.04% | 21.37% | 6,512,758.18% |
| Free Cash Flow Growth | -87.62% | -126.12% | 21.82% | -195.04% |
| Safety | ||||
| Net Debt / EBITDA | -1.33 | -1.37 | -2.45 | -3.81 |
| Interest Coverage | -35.76 | -17.64 | -5.31 | -114.16 |
| Efficiency | ||||
| Inventory Turnover | 108.40 | 71.75 | 33.03 | 52.51 |
| Cash Conversion Cycle | 44.90 | 50.16 | 56.57 | 17.02 |